Molecular organization of target of rapamycin complex 2

Stephan Wullschleger1, Robbie Loewith, Wolfgang Oppliger

  • 1Division of Biochemistry, Biozentrum, University of Basel, CH-4056 Basel, Switzerland.

Insights

Target of rapamycin complex 2 (TORC2) is an oligomeric protein complex. AVO1 and AVO3 binding is crucial for TORC2 integrity, while LST8 modulates its activity and stability.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The target of rapamycin (TOR) kinase is essential for eukaryotic cell growth.
  • TOR functions in two distinct complexes: TORC1 and TORC2.
  • TORC2 regulates the actin cytoskeleton via a rapamycin-insensitive pathway.

Purpose of the Study:

  • To characterize the structure and assembly of TORC2.
  • To investigate the roles of individual subunits in TORC2 integrity and function.
  • To explore the oligomeric nature of TORC2.

Main Methods:

  • Biochemical analysis of TORC2 complex formation.
  • Protein-protein interaction studies.
  • Analysis of subunit requirements for TORC2 integrity and kinase activity.

Main Results:

  • TORC2 exists as an oligomer, likely a dimer.
  • AVO1 and AVO3 cooperatively bind to TOR2 and are essential for TORC2 integrity.
  • LST8 binds to the kinase domain, modulating both integrity and activity.
  • TORC2 autophosphorylates AVO1 and AVO3, but this is not required for integrity.
  • Mammalian TOR was also found to be oligomeric.

Conclusions:

  • TORC2 possesses a complex oligomeric architecture.
  • Specific subunit interactions dictate TORC2 assembly and regulation.
  • Understanding TORC2 structure provides insights into its role in cell growth and cytoskeleton organization.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Directing Proteins to the Rough Endoplasmic Reticulum01:34

Directing Proteins to the Rough Endoplasmic Reticulum

The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
Cotranslational Protein Translocation01:20

Cotranslational Protein Translocation

Translocation of proteins across membranes is an ancient process that occurs even in bacteria and archaebacteria. In fact, the components of the translocation machinery are still conserved between prokaryotes and eukaryotes.
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
Protein Translocation Machinery on the ER Membrane01:28

Protein Translocation Machinery on the ER Membrane

The translocon complex situated on the ER membrane is the main gateway for the protein secretory pathway. It facilitates the transport of nascent peptides into the ER lumen and their insertion into the ER membrane.
Sec61 protein conducting channel
In eukaryotes, the translocon complex comprises a core heterotrimeric translocator channel called the Sec61 complex. This channel includes three transmembrane proteins, Sec61α, Sec61β, and Sec61γ, and is the largest subunit of the translocon complex.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...